GSK1265744 (sodium salt)(1051375-13-3)
- Name: GSK1265744 (sodium salt)
- Synonyms:Sodium Cabotegravir;Cabotegravir Sodium;GSK1265744 (sodiuM salt);GSK1265744 (sodiuM salt) ISO 9001：2015 REACH;Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate;(3S,11AR)-N-(2,4-DIFLUOROBENZYL)-6-HYDROXY-3-METHYL-5,7-DIOXO-2,3,5,7,11,11A-HEXAHYDROOXAZOLO[3,2-A]PYRIDO[1,2-D]PYRAZINE-8-CARBOXAMIDE, SODIUM SALT
- Molecular Formula:C19H16F2N3NaO5
- Molecular Weight:427.3340164
- CAS Registry Number:1051375-13-3
- EINECS:
- Melting Point:
- Water Solubility:
China (Mainland)] 
Assessed
Assessed
Assessed
Premium
Premium
Premium
Premium
Other Product
- 155294-62-5/NB 598 Maleate
- 157124-84-0/1-phosphono-4-(3-phenoxyphenyl) butylsulfonic acid tripotassiuM salt
- 61585-29-3/Impurity A of Calcifediol
- 870677-05-7/DMAPT
- 856691-93-5/CEP-11981
- 936221-33-9/CG-200745
- 1361644-26-9/INNO206
- 195883-09-1/OMTRIPTOLIDE SODIUM
- 502487-67-4/SQ 109
- 906093-29-6/Teneligliptin
- 213406-50-9/RG7304
- 902156-99-4/NVP-LCQ195
- 885692-52-4/JNJ-28312141
- 900573-88-8/JI-101
- 1346704-33-3/GSK 343
- 377769-51-2/5-(N-(4-butylphenyl)sulfamoyl)-2-methylbenzoic acid
- 1254706-36-9/N-(4-chlorophenyl)-3,6-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazole-5-sulfonamide
- 905590-62-7/N-(5-benzyl-4-phenylthiazol-2-yl)-4-(4,5-diethoxy-2-methylphenyl)-4-oxobutanamide
- 252015-00-2/(2R)-N-(2-chloro-4-((4-(methylsulfonyl)phenyl)sulfinyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide
- 1051375-13-3/GSK1265744 (sodium salt)
- 1228690-36-5/AM095
- 243982-58-3/PDHK inhibitor
- 1072906-04-7/Ethanamine, 2-(5-bromo-2-nitrophenoxy)-N,N-dimethyl-
- 701213-36-7/BMS 626529
- 1065559-56-9/SMND-309
- 1188910-76-0/CEP-32496 (free base)
- 1008763-54-9/D3263 HCl salt
- 529488-28-6/Genz644282
- 331244-89-4/BAM7
- 1065473-66-6/2-Buten-1-one, 1-[(2S)-2-[[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-1-pyrrolidinyl]-4-(dimethylamino)-, (2E)-